Click a topic below for an index of articles:

 

New-Material

Home

Alternative-Treatments

Financial or Socio-Economic Issues

Forum

Health Insurance

Hepatitis

HIV/AIDS

Institutional Issues

International Reports

Legal Concerns

Math Models or Methods to Predict Trends

Medical Issues

Our Sponsors

Occupational Concerns

Our Board

Religion and infectious diseases

State Governments

Stigma or Discrimination Issues

If you would like to submit an article to this website, email us at info@heart-intl.net for a review of this paper
info@heart-intl.net

 

any words all words
Results per page:

“The only thing necessary for these diseases to the triumph is for good people and governments to do nothing.”

   

Bush blocks deal allowing cheap drugs

George Bush's close links with the drugs industry were last night blamed for the failure of talks in Geneva aimed at securing access to cheap medicines for developing countries.

Delegates at the World Trade Organisation expressed frustration after the US again rejected a deal that would have loosened global patent rules to enable poor countries to import cheap copies of desperately needed drugs.

"We believe that governments should maintain their distance and should not be directed by pressure groups," one EU trade official said.

Negotiators said a solution to the deadlock lay in America's hands. "The pharmaceuticals lobby is running the show in Washington," one development activist said.

 

    

The WTO's 144 members agreed more than a year ago that countries could override patent rules in the interests of public health and license local producers to copy essential drugs. But they failed to spell out how countries with no manufacturing capacity would gain access to life-saving medicines.

A draft accord on imports was rejected by the US last December after lobbying from drugs firms, which fear that relaxing the rules to allow poor countries to import copycat drugs will help generics manufacturers in India and Brazil to steal their markets.

America's counter proposal, limiting imports to drugs for a shortlist of diseases including HIV/Aids, malaria and tuberculosis, was rejected by developing countries as too restrictive.

Eduardo Perez Motta, the Mexican ambassador to the WTO, who chairs the drugs talks, admitted the organisation's reputation had been damaged by the deadlock.

A Brazilian proposal, to let the World Health Organisation decide which countries were allowed to import copycat drugs, was not even discussed yesterday.

    



Last week a South African plan that would have required countries to declare a national emergency also failed to win over the US drug industry. - Guardian Unlimited © Guardian Newspapers Limited 2003